NICE-话题@MedSci

#NICE#

226篇内容 | 7546人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1289000, encodeId=b894128900043, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015 NICE技术评估指南：Vedolizumab治疗优先治疗后中重度活动性克罗恩病（TA352）, objectType=article, longId=83671, objectId=fc27836e13f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc27836e13f, replyNumber=0, likeNumber=48, createdTime=2016-12-08, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc27836e13f, moduleTitle=2015 NICE技术评估指南：Vedolizumab治疗优先治疗后中重度活动性克罗恩病（TA352）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc27836e13f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288999, encodeId=9d171288999f6, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015 NICE技术评估指南：托伐普坦治疗常染色体显性遗传性多囊性肾病（TA358）, objectType=article, longId=83669, objectId=e4ee83669a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4ee83669a8, replyNumber=0, likeNumber=43, createdTime=2016-12-08, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4ee83669a8, moduleTitle=2015 NICE技术评估指南：托伐普坦治疗常染色体显性遗传性多囊性肾病（TA358）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4ee83669a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288998, encodeId=65eb1288998fb, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016 NICE指南：HIV检测（NG.60）, objectType=article, longId=83471, objectId=4636834e167, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4636834e167, replyNumber=0, likeNumber=89, createdTime=2016-12-04, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4636834e167, moduleTitle=2016 NICE指南：HIV检测（NG.60）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4636834e167)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288997, encodeId=d604128899ed7, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=NICE推荐抗癌药“海乐卫”（Halaven）用于晚期乳腺癌的治疗, objectType=article, longId=83408, objectId=86f0834083a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86f0834083a, replyNumber=0, likeNumber=79, createdTime=2016-12-03, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86f0834083a, moduleTitle=NICE推荐抗癌药“海乐卫”（Halaven）用于晚期乳腺癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86f0834083a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288996, encodeId=fdc9128899660, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=秋裤才是冬日里的救世主!图样？给你们个最nice的！, objectType=article, longId=83293, objectId=c1118329384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1118329384, replyNumber=0, likeNumber=81, createdTime=2016-12-01, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1118329384, moduleTitle=秋裤才是冬日里的救世主!图样？给你们个最nice的！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1118329384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288995, encodeId=a6bb128899531, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016NICE技术评估指南：Secukinumab用于非甾体类抗炎药或TNF抑制剂治疗后强直性脊柱炎活动期的治疗（TA407）发布, objectType=article, longId=81136, objectId=2d358113649, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d358113649, replyNumber=0, likeNumber=97, createdTime=2016-10-28, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d358113649, moduleTitle=2016NICE技术评估指南：Secukinumab用于非甾体类抗炎药或TNF抑制剂治疗后强直性脊柱炎活动期的治疗（TA407）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d358113649)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288994, encodeId=8c321288994d9, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016NICE技术评估指南：Crizotinib用于未经治疗的间变性淋巴瘤激酶（ALK）阳性的晚期非小细胞肺癌的治疗（TA406）发布, objectType=article, longId=81135, objectId=124781135a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=124781135a7, replyNumber=0, likeNumber=45, createdTime=2016-10-28, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=124781135a7, moduleTitle=2016NICE技术评估指南：Crizotinib用于未经治疗的间变性淋巴瘤激酶（ALK）阳性的晚期非小细胞肺癌的治疗（TA406）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=124781135a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288993, encodeId=edc1128899391, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016NICE技术评估指南：osimertinib用于治疗局部晚期或转移性EGFR T790M突变阳性非小细胞肺癌（TA416）发布, objectType=article, longId=81116, objectId=25a48111657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25a48111657, replyNumber=0, likeNumber=38, createdTime=2016-10-28, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25a48111657, moduleTitle=2016NICE技术评估指南：osimertinib用于治疗局部晚期或转移性EGFR T790M突变阳性非小细胞肺癌（TA416）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25a48111657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288992, encodeId=a40e128899250, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016NICE技术评估指南：Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎（TA415）发布, objectType=article, longId=81115, objectId=cd38811156e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd38811156e, replyNumber=0, likeNumber=50, createdTime=2016-10-28, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd38811156e, moduleTitle=2016NICE技术评估指南：Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎（TA415）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd38811156e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288991, encodeId=d8ad128899153, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016NICE技术评估指南：cobimetinib联合vemurafenib治疗不能手术切除或转移性BRAF V600突变阳性黑色素瘤（TA414）发布, objectType=article, longId=81114, objectId=c6088111417, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6088111417, replyNumber=0, likeNumber=45, createdTime=2016-10-28, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6088111417, moduleTitle=2016NICE技术评估指南：cobimetinib联合vemurafenib治疗不能手术切除或转移性BRAF V600突变阳性黑色素瘤（TA414）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6088111417)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288990, encodeId=3c6c128899065, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016NICE技术评估指南：Elbasvir–grazoprevir用于治疗慢性丙型肝炎（TA413）发布, objectType=article, longId=81113, objectId=42e58111305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42e58111305, replyNumber=0, likeNumber=52, createdTime=2016-10-28, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42e58111305, moduleTitle=2016NICE技术评估指南：Elbasvir–grazoprevir用于治疗慢性丙型肝炎（TA413）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42e58111305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288989, encodeId=72c11288989d3, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015NICE技术评估指南：secukinumab治疗中重度斑块型银屑病（TA350）发布, objectType=article, longId=81033, objectId=f6618103358, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6618103358, replyNumber=0, likeNumber=48, createdTime=2016-10-27, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6618103358, moduleTitle=2015NICE技术评估指南：secukinumab治疗中重度斑块型银屑病（TA350）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6618103358)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288988, encodeId=d25712889880c, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015NICE技术评估指南：玻璃体腔内注射地塞米松治疗糖尿病性黄斑水肿（TA349）发布, objectType=article, longId=81028, objectId=081881028be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=081881028be, replyNumber=0, likeNumber=58, createdTime=2016-10-27, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=081881028be, moduleTitle=2015NICE技术评估指南：玻璃体腔内注射地塞米松治疗糖尿病性黄斑水肿（TA349）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=081881028be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288987, encodeId=0e8f128898e1d, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=Amicus Therapeutics法布里病新药Galafold获英国NICE支持批准, objectType=article, longId=80709, objectId=43e080e0996, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43e080e0996, replyNumber=0, likeNumber=88, createdTime=2016-10-24, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43e080e0996, moduleTitle=Amicus Therapeutics法布里病新药Galafold获英国NICE支持批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43e080e0996)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288986, encodeId=dd791288986ab, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015NICE技术评估指南——依维莫司预防肝移植器官排异反应（TA348）发布, objectType=article, longId=79987, objectId=c55be998774, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c55be998774, replyNumber=0, likeNumber=41, createdTime=2016-10-14, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c55be998774, moduleTitle=2015NICE技术评估指南——依维莫司预防肝移植器官排异反应（TA348）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c55be998774)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288985, encodeId=daee12889852c, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015NICE技术评估指南——依度沙班预防非瓣膜性房颤患者卒中和全身性栓塞（TA355）发布, objectType=article, longId=79986, objectId=4b64e998681, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b64e998681, replyNumber=0, likeNumber=47, createdTime=2016-10-14, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b64e998681, moduleTitle=2015NICE技术评估指南——依度沙班预防非瓣膜性房颤患者卒中和全身性栓塞（TA355）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b64e998681)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288984, encodeId=e3f31288984c9, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015NICE技术评估指南——托伐普坦治疗常染色体显性遗传性多囊肾病（TA358）发布, objectType=article, longId=79985, objectId=153ce9985ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=153ce9985ac, replyNumber=0, likeNumber=65, createdTime=2016-10-14, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=153ce9985ac, moduleTitle=2015NICE技术评估指南——托伐普坦治疗常染色体显性遗传性多囊肾病（TA358）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=153ce9985ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288983, encodeId=dad1128898359, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015NICE技术评估指南——Idelalisib治疗慢性淋巴细胞白血病（TA359）发布, objectType=article, longId=79984, objectId=9181e99846e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9181e99846e, replyNumber=0, likeNumber=67, createdTime=2016-10-14, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9181e99846e, moduleTitle=2015NICE技术评估指南——Idelalisib治疗慢性淋巴细胞白血病（TA359）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9181e99846e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288982, encodeId=adca1288982f7, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015NICE技术评估指南——阿普斯特治疗活动性银屑病关节炎（TA372）发布, objectType=article, longId=79983, objectId=a20ce9983ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a20ce9983ea, replyNumber=0, likeNumber=39, createdTime=2016-10-14, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a20ce9983ea, moduleTitle=2015NICE技术评估指南——阿普斯特治疗活动性银屑病关节炎（TA372）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a20ce9983ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288981, encodeId=466312889816a, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015NICE指南——慢性肾脏病：贫血管理（NG8）发布, objectType=article, longId=79963, objectId=92e9e9963eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92e9e9963eb, replyNumber=0, likeNumber=53, createdTime=2016-10-14, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92e9e9963eb, moduleTitle=2015NICE指南——慢性肾脏病：贫血管理（NG8）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92e9e9963eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

NICE

2020-05-29

fusion (审核中...)

前往app查看评论内容

#NICE#

2015 NICE技术评估指南：Vedolizumab治疗优先治疗后中重度活动性克罗恩病（TA352）

2016-12-08

fusion (审核中...)

前往app查看评论内容

#NICE#

2015 NICE技术评估指南：托伐普坦治疗常染色体显性遗传性多囊性肾病（TA358）

2016-12-08

fusion (审核中...)

前往app查看评论内容

#NICE#

2016 NICE指南：HIV检测（NG.60）

2016-12-04

fusion (审核中...)

前往app查看评论内容

#NICE#

NICE推荐抗癌药“海乐卫”（Halaven）用于晚期乳腺癌的治疗

2016-12-03

fusion (审核中...)

前往app查看评论内容

#NICE#

秋裤才是冬日里的救世主!图样？给你们个最nice的！

2016-12-01

fusion (审核中...)

前往app查看评论内容

#NICE#

2016NICE技术评估指南：Secukinumab用于非甾体类抗炎药或TNF抑制剂治疗后强直性脊柱炎活动期的治疗（TA407）发布

2016-10-28

fusion (审核中...)

前往app查看评论内容

#NICE#

2016NICE技术评估指南：Crizotinib用于未经治疗的间变性淋巴瘤激酶（ALK）阳性的晚期非小细胞肺癌的治疗（TA406）发布

2016-10-28

fusion (审核中...)

前往app查看评论内容

#NICE#

2016NICE技术评估指南：osimertinib用于治疗局部晚期或转移性EGFR T790M突变阳性非小细胞肺癌（TA416）发布

2016-10-28

fusion (审核中...)

前往app查看评论内容

#NICE#

2016NICE技术评估指南：Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎（TA415）发布

2016-10-28

fusion (审核中...)

前往app查看评论内容

#NICE#

2016NICE技术评估指南：cobimetinib联合vemurafenib治疗不能手术切除或转移性BRAF V600突变阳性黑色素瘤（TA414）发布

2016-10-28

fusion (审核中...)

前往app查看评论内容

#NICE#

2016NICE技术评估指南：Elbasvir–grazoprevir用于治疗慢性丙型肝炎（TA413）发布

2016-10-28

fusion (审核中...)

前往app查看评论内容

#NICE#

2015NICE技术评估指南：secukinumab治疗中重度斑块型银屑病（TA350）发布

2016-10-27

fusion (审核中...)

前往app查看评论内容

#NICE#

2015NICE技术评估指南：玻璃体腔内注射地塞米松治疗糖尿病性黄斑水肿（TA349）发布

2016-10-27

fusion (审核中...)

前往app查看评论内容

#NICE#

Amicus Therapeutics法布里病新药Galafold获英国NICE支持批准

2016-10-24

fusion (审核中...)

前往app查看评论内容

#NICE#

2015NICE技术评估指南——依维莫司预防肝移植器官排异反应（TA348）发布

2016-10-14

fusion (审核中...)

前往app查看评论内容

#NICE#

2015NICE技术评估指南——依度沙班预防非瓣膜性房颤患者卒中和全身性栓塞（TA355）发布

2016-10-14

fusion (审核中...)

前往app查看评论内容

#NICE#

2015NICE技术评估指南——托伐普坦治疗常染色体显性遗传性多囊肾病（TA358）发布

2016-10-14

fusion (审核中...)

前往app查看评论内容

#NICE#

2015NICE技术评估指南——Idelalisib治疗慢性淋巴细胞白血病（TA359）发布

2016-10-14

fusion (审核中...)

前往app查看评论内容

#NICE#

2015NICE技术评估指南——阿普斯特治疗活动性银屑病关节炎（TA372）发布

2016-10-14

fusion (审核中...)

前往app查看评论内容

#NICE#

2015NICE指南——慢性肾脏病：贫血管理（NG8）发布

2016-10-14

科室
- - 订阅+
  - 更多科室
工具
服务